Macular edema is the pathological accumulation of fluid in the central retina. It is a
complication of many retinal diseases, including diabetic retinopathy, retinal vascular�…

A short-term increase in intraocular pressure (IOP) is a common side effect after intravitreal
anti-VEGF therapy, but a sustained increase in IOP with the development of secondary�…

Age-related macular degeneration (AMD) is a complex and multifactorial disease and a
leading cause of irreversible blindness in the elderly population. The anti-vascular�…

PURPOSE Intraocular pressure increase (IOPi) after intravitreal injections of vascular
endothelial growth factor inhibitors (VEGFis) might be different among different VEGFis�…

Diabetic macular edema (DME) is a major ocular complication of diabetes mellitus (DM),
leading to significant visual impairment. DME's pathogenesis is multifactorial. Focal edema�…

In this review, we aim to provide an overview of the recent findings about the treatment of
neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed�…

Purpose To evaluate whether repeated intravitreal injections (IVI) with an anti-vascular
endothelial growth factor (anti-VEGF) agent are associated with glaucomatous progression�…

Purpose The purpose of this study was to investigate how often glaucoma and neovascular
age‐related macular degeneration (nAMD) occur in the same patient and to evaluate�…

Introduction Personalized medicine and patient-tailored drug dosing have been
substantiated through thousands of clinical studies, demonstrating their safety and efficacy�…

Background: Depression has been shown to be associated with eye diseases, including dry
eye disease (DED), cataracts, glaucoma, age-related macular degeneration (AMD), and�…